Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Pancreatic Surgery (NEUPRODEX)
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Cognition disorders; Delirium; Postoperative complications
- Focus Therapeutic Use
- Acronyms Neuprodex
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2018.
- 21 Mar 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jul 2018.